Literature DB >> 9920021

Modulation by cytokines of induction of oral tolerance to type II collagen.

G J Thorbecke1, R Schwarcz, J Leu, C Huang, W J Simmons.   

Abstract

OBJECTIVE: To determine whether the simultaneous administration of drugs and/or cytokines such as transforming growth factor beta (TGFbeta) can render oral tolerance to type II collagen (CII) more effective in causing resistance to collagen-induced arthritis (CIA) in mice, and to investigate whether oral tolerance can still be induced when high levels of anti-CII are present.
METHODS: Tolerance was induced by intragastric feeding of low-dose CII to DBA/1 mice during a 2-week period, either before immunization with CII in Freund's complete adjuvant or after initiation of arthritis. Some mice were simultaneously injected with TGFbeta1 or with the H2 receptor agonist dimaprit.
RESULTS: Both TGFbeta1 and dimaprit increased the degree of oral tolerance obtained. TGFbeta1 augmented the induction of immunoregulatory CD8 T cells, which transferred the resistance to CIA induction to normal recipients. Feeding of CII for 2 weeks, starting after the onset of arthritis, still significantly ameliorated the course of CIA.
CONCLUSION: Administration of TGFbeta1 or dimaprit, both of which are believed to promote the development of immunoregulatory T cells, may reinforce induction of oral tolerance, even after the onset of arthritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920021     DOI: 10.1002/1529-0131(199901)42:1<110::AID-ANR14>3.0.CO;2-M

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Oral tolerance of food.

Authors:  Steve Stanley
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

2.  CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation.

Authors:  G Hansen; J J McIntire; V P Yeung; G Berry; G J Thorbecke; L Chen; R H DeKruyff; D T Umetsu
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 3.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

4.  The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen.

Authors:  C Porporatto; M M Canali; I D Bianco; S G Correa
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

5.  Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis.

Authors:  C H Ding; Q Li; Z Y Xiong; A W Zhou; G Jones; S Y Xu
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 6.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Authors:  Henry Yim Wu
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

Review 7.  Oral tolerance as antigen-specific immunotherapy.

Authors:  Natália Pinheiro-Rosa; Lícia Torres; Mariana de Almeida Oliveira; Marcos Felipe Andrade-Oliveira; Mauro Andrade de Freitas Guimarães; Monique Macedo Coelho; Juliana de Lima Alves; Tatiani Uceli Maioli; Ana M Caetano Faria
Journal:  Immunother Adv       Date:  2021-08-25

8.  Oral Administration of Shark Type II Collagen Suppresses Complete Freund's Adjuvant-Induced Rheumatoid Arthritis in Rats.

Authors:  Lijuan Chen; Bin Bao; Nanping Wang; Jing Xie; Wenhui Wu
Journal:  Pharmaceuticals (Basel)       Date:  2012-03-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.